Genetic Variation in Targets of Antidiabetic Drugs and Amyotrophic Lateral Sclerosis Risk
The complex interaction between hypoglycemic, antioxidation, and anti-inflammatory effects may account for the different results across antidiabetic drug types. These findings provide key evidence to guide the use of antidiabetic drugs and will help to identify novel therapeutic targets in ALS.
Authors
- Dongsheng Fan (ORCID: https://orcid.org/0000-0002-3129-9821)
- Mengxia Wan
- Junyan Huo
- Tao Huang (ORCID: https://orcid.org/0000-0002-7645-4290)
- Linjing Zhang (ORCID: https://orcid.org/0000-0001-7309-1757)
- Yu Fu (ORCID: https://orcid.org/0009-0009-9150-4338)
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- National Health and Family Planning Commission (CN)
- Peking University Third Hospital (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3390/biomedicines12122733
- Citations
- 3
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- National Natural Science Foundation of China